Biltmore Family Office’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,715
Closed -$252K 181
2020
Q2
$252K Hold
5,715
0.15% 122
2020
Q1
$222K Sell
5,715
-66
-1% -$3.36K 0.15% 128
2019
Q4
$328K Buy
5,781
+66
+1% +$3.68K 0.13% 132
2019
Q3
$305K Hold
5,715
0.13% 127
2019
Q2
$334K Hold
5,715
0.18% 101
2019
Q1
$284K Buy
5,715
+315
+6% +$13.9K 0.14% 124
2018
Q4
$201K Hold
5,400
0.11% 138
2018
Q3
$204K Hold
5,400
0.1% 145
2018
Q2
$237K Hold
5,400
0.12% 131
2018
Q1
$272K Hold
5,400
0.12% 137
2017
Q4
$356K Buy
+5,400
New +$343K 0.16% 117

Other funds holding XRAY

Biltmore Family Office's XRAY Position: Q3 2020 in Review

Biltmore Family Office sold out of Dentsply Sirona (XRAY) in Q3 2020, closing a stake of 5,715 shares — an estimated $252K sold.

Biltmore Family Office first reported a position in XRAY in Q4 2017 and held it in 11 quarters. The position peaked at $356K in Q4 2017. 483 funds tracked by Wall St. Rank hold XRAY as of Q3 2020.

  • Biltmore Family Office reported no remaining Dentsply Sirona position as of Q3 2020 after selling out during the quarter.
  • Biltmore Family Office sold 5,715 Dentsply Sirona shares in Q3 2020, an estimated $252K.
  • Biltmore Family Office first reported a position in Dentsply Sirona in Q4 2017 and held it in 11 quarters.
  • Biltmore Family Office's Dentsply Sirona position peaked at $356K in Q4 2017.
  • 483 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2020.

Based on Biltmore Family Office's 13F filing for Q3 2020, filed 12 Nov 2020.